Evidence map›Paper›PMID 39680898›Full record

ArticleAnnals of the American Thoracic Society2025

Incidence of Pulmonary Hypertension in the Echocardiography Referral Population.

Jonah D Garry, Suman Kundu, Jeffrey Annis, Chuck Alcorn, Svetlana Eden, Emily Smith, Robert Greevy, Bradley A Maron, Matthew Freiberg, Evan L Brittain

Abstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jonah D GarryDivision of Cardiovascular Medicine.ORCID 0000-0001-9140-1632
Suman KunduVanderbilt Institute of Clinical and Translational Research, and.
Jeffrey AnnisVanderbilt Institute of Clinical and Translational Research, and.
Chuck AlcornSchool of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Svetlana EdenDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Emily SmithVanderbilt Institute of Clinical and Translational Research, and.
Robert GreevyDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Bradley A MaronDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
Matthew FreibergDivision of Cardiovascular Medicine.
Evan L BrittainDivision of Cardiovascular Medicine.

Funding

Effect of PDE5 Inhibition on Adipose Metabolism in HumansR01DK124845 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BRITTAIN, EVAN L, DAMON, BRUCE M. · 2021 to 2025
$3.4M
Clinical, Genetic, and Proteomic Risk Factors for Pulmonary Hypertension in Heart FailureR01HL146588 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BRITTAIN, EVAN L, FREIBERG, MATTHEW S · 2019 to 2022
$3.4M
NHLBI NIH HHS R01 HL 146588NIDDK NIH HHS R01 DK 124845U.S. Department of Veterans Affairs P01 AA 029545U.S. Food and Drug Administration R01 FD 007627
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EchocardiographyHeart FailureHypertension, PulmonaryPulmonary Disease, Chronic ObstructiveAgedFemaleHumansIncidenceMaleMiddle AgedReferral and ConsultationRetrospective StudiesRisk FactorsUnited Statesechocardiographyepidemiologypulmonary hypertension

Identifiers

PMID39680898
PMCPMC12051908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.